title: Serum fluctuations of total and free tryptophan levels during the menstrual cycle are related to gonadotrophins and reflect brain serotonin utilization.
abstract: BACKGROUND
  Serotoninergic (5-HT) neurons are suggested to regulate estrous cycle in animal models. In the present study we evaluated whether a relationship exists between the serotoninergic precursors in the central nervous system and the gonadotrophin-ovarian cyclic function.
  
  
  METHODS
  We measured 5-HT precursors [free (FT) and total (TT) tryptophan] and LH, FSH and 17beta-estradiol (E2) levels in the serum of 15 fertile women with normal menstrual cycles during the follicular (cycle days 1-5, 7-11), mid-cycle (cycle days 14-16) and luteal (cycle days 17-19, 22-24) phases.
  
  
  RESULTS
  TT and FT were significantly increased in the 7-11 and 17-19 cycle days and were decreased at mid-cycle (P < 0.01), with a cyclic and opposite behaviour when compared to that of FSH and LH. Indeed, correlation analysis through the matrix of mean values showed that LH was negatively correlated to TT (r = -0.636) and FT (r = -0.574), as well as FSH (TT, r = -0.655; FT, r = -0.663), and that TT and FT were positively correlated to each other (r = 0.801; P < 0.001). Furthermore, whilst the two FT peaks reached approximately the same levels in the follicular and luteal phase, TT levels were approximately 30% higher in the luteal than in the follicular phase of the cycle: thus in the first (follicular) phase FT peak was relatively higher than that of TT, whereas the contrary occurred in the second (luteal) phase of the cycle.
  
  
  CONCLUSIONS
  Both TT and FT levels have cyclic variations throughout the menstrual cycle, being lowest at mid-cycle (14-16 cycle days), concomitant with the highest LH and FSH concentrations, and higher before and after mid-cycle phase, coinciding with the lowest circulating LH/FSH levels. Since TT and FT levels in the plasma have cyclic changes, our study: (i) suggests that a consumption of serum serotonin precursors takes place concomitant with gonadotrophin release during menstrual cycle; (ii) may represent an in vivo model to investigate this relationship in women in different physiopathological conditions.
authors.affiliation: Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena Policlinico Le Scotte, Viale Bracci, 53100 Siena, Italy. carretti@unisi.it
authors.forename: N
authors.initials: N
authors.lastname: Carretti
authors.forename: P
authors.initials: P
authors.lastname: Florio
authors.forename: A
authors.initials: A
authors.lastname: Bertolin
authors.forename: C V L
authors.initials: CV
authors.lastname: Costa
authors.forename: G
authors.initials: G
authors.lastname: Allegri
authors.forename: G
authors.initials: G
authors.lastname: Zilli
mesh_terms: D000328:Adult; D001921:Brain / Q000378:metabolism*; D016000:Cluster Analysis; D004958:Estradiol / Q000097:blood; D005260:Female; D006065:Gonadotropins, Pituitary / Q000097:blood*; D006801:Humans; D008597:Menstrual Cycle / Q000502:physiology*; D012016:Reference Values; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D014364:Tryptophan / Q000097:blood*
chemical_list: D006065:Gonadotropins, Pituitary; D012701:Serotonin; D004958:Estradiol; D014364:Tryptophan